CVE-2017-2869An exploitable code execution vulnerability exists in the OpenProducer functionality of Natus Xltek NeuroWorks 8.
Updated under an hour ago ()
Does this affect you?
It affects Natus Medical Incorporated Natus and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 2.62%, higher than 85% of scored CVEs.
Do this next
Free account, 1 product
An exploitable code execution vulnerability exists in the OpenProducer functionality of Natus Xltek NeuroWorks 8. A specially crafted network packet can cause a stack buffer overflow resulting in code execution. An attacker can send a malicious packet to trigger this vulnerability.
- CVSS
- 10.0 CRITICAL (v3.0, CNA)CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
- Weakness (CWE)
- Not given
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 2.62% (percentile 85)
- Assigned by
- talos
- NVD analysis
- Modified
- Record last updated
- Sep 17, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
Natus Medical Incorporated Natus natus_medical:natus (from the name) | Natus Xltek NeuroWorks 8 | CNA record |
natus xltek_neuroworks natus:xltek_neuroworks | 8 | NVD |
References
- http://www.securityfocus.com/bid/104490vdb-entry, x-refsource-bid, broken-link
- https://talosintelligence.com/vulnerability_reports/TALOS-2017-0375x-refsource-misc, third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.